Cancer-related post-treatment pain and its impact on health-related quality of life in breast cancer patients: a cross sectional study in Palestine

Table 2 Cancer current condition and health-related quality of life

Variable	n (%) N = 170	Median EQ-5D-5L index (1st percentile-3rd percentile)	P value
Type of breast cancer
Invasive ductal carcinoma	159 (93.5)	0.67 [0.52–0.84]	0.419^a
Invasive lobular carcinoma	6 (3.5)	0.49 [0.25–0.77]
Ductal carcinoma in situ	5 (2.9)	1.00 [0.81–1.00]
Stage of cancer^c
Stage 1	58 (34.1)	0.72 [0.55–0.85]	0.125^a
Stage 2	24 (14.1)	0.61 [0.52–0.77]
Stage 3	40 (23.5)	0.67 [0.51–0.81]
Stage 4	47 (27.6)	0.60 [0.37–0.88]
Current condition
Cancer-free	60 (35.3)	0.74 [0.55–0.85]	0.023 ^a
The tumor returned	30 (17.6)	0.62 [0.51–0.85]
Active and receiving treatment	80 (47.1)	0.64 [0.37–0.77]
Last time received treatment
0–3 months	104 (61.2)	0.65 [0.41–0.84]	0.310^a
3–12 months	16 (9.4)	0.59 [0.51–0.77]
1–2 years	24 (14.1)	0.74 [0.63–0.84]
More than 2 years	26 (15.3)	0.67 [0.53–0.86]
Post-treatment pain
Yes	149 (87.6)	0.65 [0.48–0.80]	0.013 ^b
No	21 (12.4)	0.85 [0.58–1.00]	0.013 ^b

Italic values indicate significance of p value (p < 0.05)
^aStatistical significance of differences calculated using the Kruskal–Wallis test
^bStatistical significance of differences calculated using the Mann–Whitney U test
^cUnknown stage of cancer for one case

ISSN: 1447-056X